Pharming Group NV (PHARM) — Defensive Interval Ratio

Latest as of September 2025: 321 days

Pharming Group NV (PHARM) has a Defensive Interval Ratio of 321 days as of September 2025. Defensive assets of €77.40 Million (cash €-, short-term investments €33.80 Million, receivables €43.61 Million) cover 321 days of daily cash needs of €240.86K/day. Check how tangible is Pharming Group NV's equity to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

321 days
Days of operational coverage

Defensive Assets

€77.40 Million
Cash + ST Investments + Receivables

Daily Cash Need

€240.86K
Current Liabilities ÷ 365

Current Liabilities

€87.91 Million
EUR

Pharming Group NV Defensive Interval Ratio (2005–2024)

This chart shows how Pharming Group NV's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 321 days, meaning defensive assets of €77.40 Million can fund 321 days of operations without new revenue. Also explore how fast is Pharming Group NV growing its equity to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Pharming Group NV (2005–2024)

The table below presents the year-by-year Defensive Interval Ratio for Pharming Group NV from 2005 to 2024, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Pharming Group NV.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 779 days €157.48 Million €202.20K/day €- €109.03 Million ▼ -131 days
2023 910 days €175.89 Million €193.37K/day €- €137.31 Million ▲ +741 days
2022 169 days €27.62 Million €163.56K/day €- €0.00 ▼ -65 days
2021 234 days €29.95 Million €128.00K/day €- €- ▲ +83 days
2020 151 days €31.94 Million €210.87K/day €- €- ▲ +70 days
2019 82 days €25.62 Million €312.68K/day €- €-661.91K ▲ +11 days
2018 71 days €18.30 Million €258.86K/day €- €- ▲ +7 days
2017 64 days €12.22 Million €192.37K/day €- €- ▼ -17 days
2016 81 days €11.97 Million €148.04K/day €- €- ▼ 0 days
2015 81 days €3.27 Million €40.36K/day €- €- ▲ +46 days
2014 35 days €1.71 Million €49.55K/day €- €- ▲ +17 days
2013 17 days €849.24K €48.90K/day €- €- ▲ +1 days
2012 17 days €538.26K €32.49K/day €- €- ▼ -12 days
2011 29 days €830.24K €28.89K/day €- €- ▼ -64 days
2010 93 days €3.28 Million €35.29K/day €- €- ▲ +93 days
2009 0 days €0.00 €142.37K/day €- €- ▼ -109 days
2008 109 days €5.22 Million €47.87K/day €- €5.22 Million ▲ +109 days
2007 0 days €1.00 €94.07K/day €- €- ▲ +0 days
2006 0 days €0.00 €33.24K/day €- €- ▼ -435 days
2005 435 days €8.05 Million €18.52K/day €- €6.92 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)